How Much Did Pharmaceutical Diagnostic Group Raise?
Funding & Key Investors

Pharmaceutical Diagnostic Group has successfully secured a major strategic investment, marking a significant milestone in its corporate trajectory. With a total capital accumulation reaching $100K, the firm continues to solidify its market presence. This latest infusion of $100K underscores the confidence institutional partners maintain in the company's operational model and its capacity to scale within the competitive healthcare services sector.

The financing round, finalized in mid-2026, provides the necessary liquidity to accelerate the deployment of advanced medical technologies and expand the firm's footprint in physician ancillary consulting and specialized dispensing platforms.

What is Pharmaceutical Diagnostic Group?

Pharmaceutical Diagnostic Group
ManufacturingMedical Devices & EquipmentBusiness Services

Pharmaceutical Diagnostic Group operates as a multifaceted provider of medical products and clinical services, bridging the gap between complex healthcare logistics and direct patient care. The company's portfolio includes high-utility assets such as the Squid Cold Compression device and the DevonMD DVT prevention system, which are engineered to improve recovery metrics and operational efficiency for healthcare providers. By focusing on the intersection of workers' compensation, personal injury, and chronic care management, the organization serves as a critical partner for medical practices seeking to diversify their revenue streams while simultaneously enhancing patient outcomes through evidence-based interventions.

How much funding has Pharmaceutical Diagnostic Group raised?

Pharmaceutical Diagnostic Group has raised a total of $100K across 1 funding round:

2026

Debt

$100K

Debt (2026): $100K with participation from Northeast Bank

Key Investors in Pharmaceutical Diagnostic Group

Northeast Bank

A regional financial institution providing commercial banking services and debt financing solutions to support the growth of established healthcare enterprises.

What's next for Pharmaceutical Diagnostic Group?

With this late-stage capital injection, Pharmaceutical Diagnostic Group is positioned to transition into a phase of aggressive market penetration and infrastructure optimization. The strategic roadmap likely involves scaling the commercial healthcare dispensing platforms to meet the rising demand for integrated care solutions. Furthermore, the firm is expected to leverage this investment to refine its supply chain for surgical supplies, ensuring that healthcare providers maintain access to essential diagnostic and therapeutic tools. As the company matures, the focus will shift toward long-term sustainability and the potential for further consolidation within the ancillary medical services market, ensuring that their clinical offerings remain at the forefront of modern healthcare delivery.

See full Pharmaceutical Diagnostic Group company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturing
Building MaterialsManufacturingGlass & Clay
ManufacturingPlastic, Packaging & Containers
Industrial Machinery & EquipmentManufacturingOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)Retail

Frequently Asked Questions Regarding Pharmaceutical Diagnostic Group Financial Insights

What are the most recent funding rounds that Pharmaceutical Diagnostic Group has completed, and what were the funding rounds?
Pharmaceutical Diagnostic Group has recently completed 1 funding rounds: Debt on Jun 5, 2026.
What is the total amount of funding Pharmaceutical Diagnostic Group has raised to date?
Pharmaceutical Diagnostic Group has raised a total of $100K in funding to date.
How many funding rounds has Pharmaceutical Diagnostic Group completed?
Pharmaceutical Diagnostic Group has completed 1 funding rounds.
How much funding did Pharmaceutical Diagnostic Group raise in its most recent funding round?
Pharmaceutical Diagnostic Group raised $100K in its most recent funding round.
Who are the lead investors in Pharmaceutical Diagnostic Group's latest funding round?
The lead investor in Pharmaceutical Diagnostic Group's latest funding round was Northeast Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Pharmaceutical Diagnostic Group's history?
The largest funding round in Pharmaceutical Diagnostic Group's history was $100K.
See more information about Pharmaceutical Diagnostic Group